Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-938-6 | CAS number: 678966-16-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation:
The study was performed in accordance with OECD Guideline 429. In this assay the test/control ratios obtained for 2.5, 5 and 10% w/v were 20.1, 15.5 and 23.7 respectively which indicates that the test substance showed the potential to induce skin sensitization (delayed contact hypersensitivity).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2010-01-07 to 2010-01-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- Batch No.: 08111121
Purity: 98% - Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd.
- Age at study initiation: approximately 8-12 weeks old
- Weight at study initiation: 17.1 to 20.7 g
- Housing: housed individually in polycarbonate cages with woodflake bedding.
- Diet (e.g. ad libitum): free access to a standard rodent diet (Rat and Mouse No. 1 Maintenance Diet).
- Water (e.g. ad libitum): freely available via polycarbonate bottles fitted with sipper tubes
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 23 °C
- Humidity (%): 40 to 70%
- Photoperiod (hrs dark / hrs light): a cycle of 12 hours continuous light and 12 hours continuous dark per 24 hours - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Preliminary study : 25 and 10% (w/v)
Main study: 2.5, 5 and 10% (w/v) - No. of animals per dose:
- 1 female per dose in the preliminary study
4 females per dose level in the main study - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: In a vehicle trial, the test substance was found to form an offwhite fine suspension at 50% (w/v) in Acetone : olive oil (4:1 v/v).
- Selection of dose levels
The maximum practical concentration for pinna dosing was 50% w/v in acetone: olive oil (4:1 v/v). However, in a previous acute oral toxicity study, deaths were seen at 300 mg/kg.
Based on this information the following concentrations were selected for the preliminary investigation: 25 and 10% w/v
Due to signs of toxicity seen after the second application in the animal dosed at 25% w/v, the results of the preliminary investigation indicated that 10% w/v was a suitable high dose level for the main phase of the study. Based on this information the following concentrations were selected for the main phase of the study: 2.5, 5 and 10% w/v
Preliminary investigation
Two females were treated at one of two concentrations of the test substance. The mice were treated by daily application of 25 μl of appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days (Days 1-3).
Main study
Groups of four mice were treated at one of three concentrations of the test substance. The mice were treated by daily application of 25 μl of appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days (Days 1-3).
Administration of 3H-methyl Thymidine
In the main phase of the study, five days following the first topical application of test substance (Day 6) all mice were injected via the tail vein with 250 μl of phosphate buffered saline containing 3H-methyl Thymidinea (3HTdR: 80 μCi/mL) giving a nominal 20 μCi to each mouse. The injection into the tail vein was carried out using a plastic syringe and needle after the mouse had been heated in a warming chamber. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- In this assay the test/control ratio obtained for HCA at 25% was 6.0. This indicates that HCA demonstrates the potential to induce skin sensitization (delayed contact hypersensitivity) and confirms the sensitivity ofthe technique to detect sensitization potential..
- Key result
- Parameter:
- SI
- Value:
- 20.1
- Test group / Remarks:
- 2.5% w/v
- Key result
- Parameter:
- SI
- Value:
- 15.5
- Test group / Remarks:
- 5% w/v
- Key result
- Parameter:
- SI
- Value:
- 23.7
- Test group / Remarks:
- 10% w/v
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- In this assay the test/control ratios obtained for 2.5, 5 and 10% w/v were 20.1, 15.5 and 23.7 respectively which indicates that the test substance showed the potential to induce skin sensitization (delayed contact hypersensitivity).
- Executive summary:
The study was performed to assess the skin sensitization potential of the test substance using the murine local lymph node assay (LLNA) according to OECD Guideline 429.
In order to find a suitable level for the main phase of the study, a preliminary investigation was conducted. Two females were dosed at either 25 or 10% w/v in acetone: olive oil (4: 1 v/v). Results indicated that 10% w/v was a suitable high dose level for the main phase of the study.
In the main phase of the study, the mice were treated by daily application of 25 μl of each of one of these three concentrations (the mice in the preliminary phase of the study were treated by daily application of 25 μl of the material at 25 or 10% w/v) or vehicle control to the dorsal surface of both ears for three consecutive days.
In the main phase of the study, the proliferative response of the lymph node cells (LNC) from the draining auricular lymph nodes was assessed five days following the initial application, by measurement of the incorporation of 3H-methyl Thymidine 3HTdR) by ß-scintillation counting of LNC suspensions. The response was expressed as radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (test/control ratio).
In this assay the test/control ratios obtained for 2.5, 5 and 10% w/v were 20.1, 15.5 and 23.7 respectively which indicates that the test substance showed the potential to induce skin sensitization (delayed contact hypersensitivity).
Responses to the positive control substance hexyl cinnamic aldehyde (HCA), in a contemporaneous study demonstrate the reliability and sensitivity of this assay to detect skin sensitization potential in this laboratory.
The test substance is regarded as a potential skin sensitizer.
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study are available
Referenceopen allclose all
Preliminary investigation
In the preliminary study, the Group 1 female dosed at 25% w/v was sacrificed on Day 2 of dosing due to the clinical signs seen. Greasy fur was noted post dose from Day 1, and was still apparent at sacrifice on Day 2. An hour after dosing on Day 2, a convulsion was noted lasting approximately 15 seconds, this was accompanied by tremors and partially closed eyelids. No signs of ill health or toxicity were observed for the Group 2 female dosed at 10% w/v. However the following observations were noted: Greasy fur was noted post dose from Day 1, and was still apparent at sacrifice on Day 4. No signs of irritation were seen over the dosed area at either level during the study.
Bodyweight increases were recorded for both mice over the period of the preliminary study. On the basis of the results from the preliminary investigation, 10% w/v was considered a suitable high dose level for the main phase of the study.
Main phase
In the main study, there were no deaths and no signs of ill health or toxicity observed during this study. However the following observations were noted: Greasy fur was noted for all control and test animals post-dose from Day 1. This sign had resolved completely in all but two females in Group 5 by Day 6. No signs of irritation were seen over the dosed area during the study. Losses in bodyweight were recorded for one female in Group 4, one female in Group 5 and 3 females in Group 6 during the study. All remaining animals gained weight during the study.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Skin sensitisation:
The study was performed to assess the skin sensitization potential of the test substance using the murine local lymph node assay (LLNA) according to OECD Guideline 429.
In order to find a suitable level for the main phase of the study, a preliminary investigation was conducted. Two females were dosed at either 25 or 10% w/v in acetone: olive oil (4: 1 v/v). Results indicated that 10% w/v was a suitable high dose level for the main phase of the study.
In the main phase of the study, the mice were treated by daily application of 25 μl of each of one of these three concentrations (the mice in the preliminary phase of the study were treated by daily application of 25 μl of the material at 25 or 10% w/v) or vehicle control to the dorsal surface of both ears for three consecutive days.
In the main phase of the study, the proliferative response of the lymph node cells (LNC) from the draining auricular lymph nodes was assessed five days following the initial application, by measurement of the incorporation of3H-methyl Thymidine3HTdR) by ß-scintillation counting of LNC suspensions. The response was expressed as radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (test/control ratio).
In this assay the test/control ratios obtained for 2.5, 5 and 10% w/v were 20.1, 15.5 and 23.7 respectively which indicates that the test substance showed the potential to induce skin sensitization (delayed contact hypersensitivity).
Responses to the positive control substance hexyl cinnamic aldehyde (HCA), in acontemporaneous study demonstrate the reliability and sensitivity of this assay to detect skin sensitization potential in this laboratory.
The test substance is regarded as a potential skin sensitizer.
Justification for classification or non-classification
In according to Regulation (EC) 1272/2008 (amendment 286/2011) Table 3.4.2, substances shall be classified as respiratory sensitisers (Category 1) if there are positive results from an appropriate animal test.
As a test/control ratio of more than 3 was recorded for all three of the concentrations tested, which indicates a positive result (Test/control of 3 or greater indicates a positive result), therefore this substance should be classified as Category 1 for skin sensitisation endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.